ARCHIVES

In Brief: Ireland Cancer Center Named Comprehensive; UPCI Appoints Four Program Directors

This article is from The Cancer Letter archive.

Vol. 24 No. 08 | February 27, 1998

Download PDF Visit The Full Archive

Related Articles

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

UT Board Announces Support for MD Anderson Tenure System

October 10, 2014

Buenos Aires Academy Denies Argentina Prosecutes Scientist

July 28, 1978

Women With Early Breast Cancer Can Wait Up To 12-Weeks For Chemo, Study Finds

October 27, 2006

California Hospital Raises $22 Million For New Cancer Center

September 14, 1990

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005